Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

MGI Tech's AI Unit Targets National Labs and Pharma Firms with Autonomous Lab Tools

Deep News
·
Aug 10

SDIC Securities: Pharmaceutical Equipment Sector Enters New Quality Upgrade Phase, Focus on Top Domestic Firms

Stock News
·
Aug 10

Mgi Tech Surges Over 19% as AI Enters Industrialization Phase, Company Provides Sequencing Tools for AI Drug Discovery

Stock News
·
Aug 10

Genscript Bio's Shares Surge Over 8% Intraday as Global AI Drug Development Enters a Realization Phase

Deep News
·
Aug 10

AI Drug Discovery Enters Validation Phase, Shares of Insilico Medicine Surge Over 11%

Deep News
·
Aug 10

Innovation in Biotech: Synthetic Biology, Equipment Localization, and New Growth Paths for Chinese Pharma Equipment

Deep News
·
Aug 06

Zhejiang Jiuzhou Pharmaceutical Reports Adding Three New Global Top-Tier Pharma Clients in Recent Years

Deep News
·
Aug 05

United Kingdom's High-End Chemical Industry Accelerates Decline, Straining Pharmaceutical and Defense Supply Chains

Deep News
·
Aug 05

Ocumension reports stable share base and sufficient public float in July 2026 disclosure

Bulletin Express
·
Aug 05

Ascletis Pharma Shares Surge 5% on Global Phase 3 Trial Launch for GLP-1 Oral Drug ASC30

Deep News
·
Aug 04

Shares of Sumitomo Pharma and Sumitomo Chemical Decline Following Short-Seller Report

Deep News
·
Aug 04

Zelgen Biopharma Reports First-Ever Half-Year Profit with Net Income of 640 Million Yuan

Stock News
·
Jul 31

ASCLETIS-B (01672) Spends HK$1.76 Million to Buy Back 200,000 Shares on July 29

Stock News
·
Jul 29

Legal Action Advances Against Nanxin Pharma as Some Investors File Lawsuits

Deep News
·
Jul 29

Auditor Fined for Acting as Fraud Accomplice, Company Forced to Delist After Inflating Profits by 669 Million Yuan Over Two Years

Deep News
·
Jul 29

Investor Compensation Cases for Poly Pharmaceutical and Changjiang Health Both Filed with Courts Again

Deep News
·
Jul 29

Buchang Pharma (603858.SH) Plans to Establish Shandong Buchang Shengshi Pharmaceutical Subsidiary

Stock News
·
Jul 28

TYK Medicines-B Shares Surge Over 5% as Qilu Pharma Secures Exclusive Rights for Lung Cancer Drug TY-9591

Deep News
·
Jul 27

Firm and Three CPAs Ordered to Forfeit Nearly 7.8 Million Yuan for Audit Failures

Deep News
·
Jul 25

PanGu Accounting Firm and Three CPAs Fined 7.8 Million Yuan by CSRC

Deep News
·
Jul 25